Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

20081,928 citationsJournal Articlebronze Open Access

Authors

Barry M. Massie · University of California, San Francisco

Peter E. Carson · Georgetown University

John J.V. McMurray · University of Glasgow

Michel Komajda · Pitié-Salpêtrière Hospital

Robert S. McKelvie · Hamilton Health Sciences

Michael R. Zile · Ralph H. Johnson VA Medical Center

Susan Anderson

Abstract

Irbesartan did not improve the outcomes of patients with heart failure and a preserved left ventricular ejection fraction. (ClinicalTrials.gov number, NCT00095238.)

Topics & Keywords

Heart Failure Treatment and Management Cardiac pacing and defibrillation studies Cardiovascular Function and Risk Factors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 359, Issue 23, pp. 2456-2467

DOI: 10.1056/nejmoa0805450

Field-Weighted Citation Impact: 60.37